Nanostics Inc.

Purpose

The goal of this project is to grow the awareness and adoption of the Firm's prostate test in North America. This novel test that can detect clinically significant prostate cancer via an accurate and minimally invasive test that can reduce healthcare costs and decrease unneeded biopsies and treatments for prostate cancer. The test is currently available in Canada as a laboratory-developed test with appropriate accreditation in the United States. The project will support a targeted key opinion leader campaign that will facilitate regulatory and reimbursement activities that are essential for market penetration.